solution
Showing 26 - 50 of >10,000
Molluscum Contagiosum Trial in Abbottabad (Group A received cryotherpay, Group B received 10% Potassium Hydroxide Solution)
Completed
- Molluscum Contagiosum
- Group A received cryotherpay
- Group B received 10% Potassium Hydroxide Solution
-
Abbottābād, Khyber Pakhtunkhwa, PakistanCMH Abbottabad
May 31, 2023
Dose, Midazolam, Preoperative Trial in Guangzhou (Midazolam oral solution)
Not yet recruiting
- Dose
- +2 more
- Midazolam oral solution
-
Guangzhou, Guangdong, Chinathe Sixth Affiliated Hospital, Sun Yat-sen University
Aug 24, 2023
Postoperative Complications Trial (Unblinded postoperative vital sign monitoring, Blinded postoperative vital sign monitoring)
Not yet recruiting
- Postoperative Complications
- Unblinded postoperative vital sign monitoring
- Blinded postoperative vital sign monitoring
- (no location specified)
Nov 9, 2023
Dry Eye Disease Trial in Bellaire (Topical spironolactone ophthalmic solution, 0.005 mg/cc, Placebo)
Not yet recruiting
- Dry Eye Disease
- Topical spironolactone ophthalmic solution, 0.005 mg/cc
- Placebo
-
Bellaire, TexasRichard W Yee, MD PLLC
Aug 16, 2023
Postpartum, Breastfeeding, Self Efficacy Trial in Eskisehir (solution oriented approach)
Recruiting
- Postpartum
- +2 more
- solution oriented approach
-
Eskisehir, Eskişehir, TurkeyEskisehir Osmnagazi Universty
Dec 23, 2022
Corneal Epithelial Degeneration Trial in Cypress (TTHX1114(NM141) Ophthalmic Solution)
Recruiting
- Corneal Epithelial Degeneration
- TTHX1114(NM141) Ophthalmic Solution
-
Cypress, CaliforniaTrefoil Clinical Site #132
Mar 3, 2023
Allergic Conjunctivitis Trial in Adelaide (MDI-1228_mesylate Ophthalmic Solution, Placebo)
Recruiting
- Allergic Conjunctivitis
- MDI-1228_mesylate Ophthalmic Solution
- Placebo
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Jul 24, 2023
Epilepsy Trial (UNEEG EpiSight solution)
Not yet recruiting
- Epilepsy
- UNEEG EpiSight solution
- (no location specified)
Jun 22, 2023
Fuchs Dystrophy, Cataract Trial in Town And Country (BSS Plus, BSS)
Recruiting
- Fuchs Dystrophy
- Cataract
- BSS Plus
- BSS
-
Town And Country, MissouriSt. Louis Eye Institute
May 11, 2023
Non-Genital Warts Trial (garlic extract (15%) solution, topical chlorhexidine (2%) solution, Saline)
Not yet recruiting
- Non-Genital Warts
- garlic extract (15%) solution
- +2 more
- (no location specified)
Oct 13, 2023
Pancreatitis, Chronic, Pancreatic Duct Stone Trial (Lactated ringers solution, normal saline)
Not yet recruiting
- Pancreatitis, Chronic
- Pancreatic Duct Stone
- Lactated ringers solution
- normal saline
- (no location specified)
Mar 15, 2023
Mitral Valve Surgery Trial in Cairo (Crystalloid Cardioplegic solution)
Completed
- Mitral Valve Surgery
- Crystalloid Cardioplegic solution
-
Cairo, EgyptAzhar University
Apr 1, 2023
Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035%
Not yet recruiting
- Allergic Conjunctivitis
- rimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution (Combo)
- Vehicle of brimonidine tartrate 0.025%/ketotifen fumarate 0.035% ophthalmic solution
- (no location specified)
Apr 4, 2023
Oral Lichen Planus, Mucous Membrane Pemphigoid, Pemphigus Vulgaris Trial in San Francisco (dexamethasone 0.5mg/5ml solution,
Completed
- Oral Lichen Planus
- +3 more
- dexamethasone 0.5mg/5ml solution
- dexamethasone 0.5mg/5ml solution in Mucolox™
-
San Francisco, CaliforniaSol Silverman Oral Medicine Clinic - UCSF
Jan 6, 2023
Metastatic Breast Cancer Trial (Meritup oral solution)
Not yet recruiting
- Metastatic Breast Cancer
- Meritup oral solution
- (no location specified)
Nov 29, 2023
Cataract, Glaucoma, Ocular Hypertension Trial in Glendale (Bimatoprost Implant System (High Dose), Bimatoprost Implant System
Recruiting
- Cataract
- +2 more
- Bimatoprost Implant System (High Dose)
- +4 more
-
Glendale, ArizonaArizona Advanced Eye Research Institute
Nov 8, 2023
Electrolyte Imbalance, Kidney Transplant; Complications Trial (Ringer's Lactate Crystalloid Solutions, Normal saline)
Not yet recruiting
- Electrolyte Imbalance
- Kidney Transplant; Complications
- Ringer's Lactate Crystalloid Solutions
- Normal saline
- (no location specified)
Sep 7, 2023
Primary Open Angle Glaucoma (POAG), Primary Open Angle Glaucoma of Both Eyes, Primary Open-Angle Glaucoma, Unspecified Eye Trial
Not yet recruiting
- Primary Open Angle Glaucoma (POAG)
- +3 more
- Experimental: QLS-111 ophthalmic solution, (0.015%)
- +4 more
- (no location specified)
Aug 30, 2023
Food Preferences, Appetitive Behavior Trial (Conditioned Stimulus: Sucrose (aim 1), Conditioned Stimulus: Glucose (aim 1),
Not yet recruiting
- Food Preferences
- Appetitive Behavior
- Conditioned Stimulus: Sucrose (aim 1)
- +5 more
- (no location specified)
Aug 24, 2023
Open Angle Glaucoma Trial (NCX 470, Placebo)
Not yet recruiting
- Open Angle Glaucoma
- NCX 470
- Placebo
- (no location specified)
Jul 6, 2023
(PMCF) to Evaluate Safety and Performance of
Completed
- Wounds
- Granudacyn/Veriforte
-
Salzburg, AustriaPGF Industry Solutions GmbH
Oct 9, 2023
Dry Eye Disease Trial in Andover (Reproxalap Ophthalmic Solution (0.25%), Placebo Comparator)
Completed
- Dry Eye Disease
- Reproxalap Ophthalmic Solution (0.25%)
- Placebo Comparator
-
Andover, MassachusettsAndover Eye Associates
Jan 24, 2023
Bowel Preparation Trial in Nanjing (OSS, OSS+Linzess, PEG-Interferon Alfa)
Recruiting
- Bowel Preparation
- OSS
- +2 more
-
Nanjing, Jiangsu, ChinaA single-center, single-blind, randomized controlled clinical st
Oct 20, 2023
SARS-CoV2 Infection Trial in Larissa (Hypertonic seawater solution)
Completed
- SARS-CoV2 Infection
- Hypertonic seawater solution
-
Larissa, Thessaly, GreeceUniversity Hospital of Larissa
Feb 15, 2023
Fasting Trial in Jakarta (Oral carbohydrate-electrolyte solution, Control)
Recruiting
- Fasting
- Oral carbohydrate-electrolyte solution
- Control
-
Jakarta, DKI Jakarta, IndonesiaCiptomangun Kusumo Hospital
Feb 6, 2023